Does a common hormone condition put young women on a path to heart disease?
Yes. In a study of 413,450 US women, PCOS heart disease risk was about 4.4 times higher than in women without the condition. About 12 percent of the women with the syndrome developed artery disease over roughly 10 years, compared with about 4 percent of the comparison group.
The condition has just been renamed. What most people know as polycystic ovary syndrome (PCOS) is now called polyendocrine metabolic ovarian syndrome, or PMOS. The new name says something important about the disease. It is not only an ovary problem. It involves several hormone systems and the way the body handles sugar and fat, which is exactly why the heart keeps showing up in the research.
What the data show
Researchers at the University of Rochester and the University of Pennsylvania compared 413,450 women diagnosed with PMOS against more than 2 million women without it. Over about a decade, roughly 12 percent of the PMOS group developed atherosclerotic cardiovascular disease, meaning cholesterol buildup in the arteries. In the comparison group it was roughly 4 percent. That is an absolute difference of about 8 percentage points, or about 80 extra cases per 1,000 women over 10 years. In the researchers’ analysis, that worked out to about 4.4 times the risk, which is roughly a 340 percent increase.
Which problems went up the most
The risk was not spread evenly across every type of heart and blood vessel event. Heart attack and ischemic stroke, the kind of stroke caused by a blocked artery, were each about 3.5 times more likely in women with PMOS. Transient ischemic attack, sometimes called a warning stroke, and peripheral artery disease, which is clogged arteries in the legs, were each about 5 times more likely. The pattern is telling. This is not one narrow problem in one organ. It looks like artery disease spreading through the whole circulatory system.
Dr. Kumar’s Take
The number that stops me is the age. These women started out at an average age of 31. We are used to thinking about heart risk as a conversation for someone’s fifties, so a fourfold difference showing up in a group this young should change how we screen. The part I find most useful clinically is that the higher risk stayed even after the researchers accounted for obesity, high blood pressure, high cholesterol, and diabetes. That tells me I cannot look at a young woman with PMOS, see a normal weight and normal blood pressure, and assume her arteries are fine. Something else is driving this.
Beyond the usual risk factors
Women with PMOS often carry the classic heart risks. They are more likely to have extra weight, insulin resistance, high blood pressure, and abnormal cholesterol. The obvious assumption is that those conditions explain the heart disease. This study argues against that being the whole story. When the researchers adjusted for all four, the gap in risk narrowed but did not close. That points to biology built into the syndrome itself, likely chronic inflammation, high insulin levels, and hormone imbalance acting directly on blood vessel walls.
Limits worth knowing
This is insurance claims data covering 2000 to 2022, not a controlled trial. Claims records show what was billed, not what a doctor examined, so some women with PMOS were almost certainly missed and coded as healthy. Because the condition is often diagnosed late, the women who did get diagnosed may have had more severe disease and more medical attention overall. A study like this can show a strong link, but it cannot prove that PMOS itself causes the artery damage. It also cannot tell us whether treating the syndrome earlier lowers heart risk.
Practical takeaways
- If you have been diagnosed with PCOS or PMOS, ask your doctor for a cardiovascular risk assessment now rather than waiting until your forties, including blood pressure, a full cholesterol panel, and a blood sugar or A1c test.
- Do not let a normal weight or normal blood pressure reassure you completely, since this study found extra risk that persisted even after accounting for those factors.
- Learn the warning signs of the events that rose most in this study, including sudden leg pain when walking and brief episodes of weakness, numbness, or slurred speech that resolve on their own.
- Bring up the condition by name at general medical visits, because a diagnosis made years ago in a gynecology office may not be in front of the doctor checking your heart.
Related studies and research
- Shingles vaccine cuts heart attack risk nearly in half for heart disease patients
- Ultra-processed foods linked to 47% higher heart disease risk
- A plant-based diet lowered heart disease risk over 20 years
- Insomnia plus sleep apnea raises heart disease risk nearly 4-fold
FAQs
Why was polycystic ovary syndrome renamed?
The old name pointed at the ovaries and at cysts, and both parts were misleading. The fluid-filled sacs seen on ultrasound are not true cysts, and plenty of women meet the diagnostic criteria without them. Meanwhile the condition reliably involves insulin, androgens, and other hormone systems throughout the body. The new name, polyendocrine metabolic ovarian syndrome, describes a whole-body hormone and metabolic condition instead of a single organ finding. Findings like this one, where the biggest consequences show up in the arteries rather than the ovaries, are part of the reason for the change.
How many women does this affect?
Roughly 1 in 10 women of reproductive age have the condition, which makes it one of the most common hormone disorders in women. That prevalence is what turns this study’s risk numbers into a public health issue rather than a niche finding. Many of those women were diagnosed during fertility workups or after irregular periods, then never followed for heart risk afterward. If you were told years ago that you had PCOS and the conversation ended there, this study is a reason to reopen it.
Does a PMOS diagnosis mean heart disease is inevitable?
No. Even in the higher-risk group, about 88 percent did not develop atherosclerotic cardiovascular disease during the follow-up period. A 4.4 times higher risk is a strong signal about a group, not a prediction about any one person. The practical value of a number like this is that it justifies earlier screening and closer attention to the risks you can act on, including blood pressure, blood sugar, cholesterol, smoking, activity, and sleep. This study was not designed to test whether earlier treatment changes the outcome, so that remains an open question.
Should younger women with PMOS get heart imaging or just blood tests?
That decision belongs with your own physician, and this study does not answer it. What the results support is starting the risk conversation much earlier than usual, since the women here were tracked from an average age of 31. For most people, that conversation begins with the basics: blood pressure, cholesterol, blood sugar, family history, and symptoms. Advanced imaging is usually reserved for those whose basic numbers or symptoms suggest a higher likelihood of disease.
Bottom line
In one of the largest analyses of its kind, women with polyendocrine metabolic ovarian syndrome were about 4.4 times more likely to develop atherosclerotic cardiovascular disease than women without it, with about 12 percent affected over 10 years compared with about 4 percent. The elevated risk held after accounting for obesity, high blood pressure, high cholesterol, and diabetes, which suggests the syndrome damages arteries through pathways of its own. For a condition affecting about 1 in 10 women of reproductive age, that is a strong argument for treating a PMOS diagnosis as a cardiovascular one too, starting in a woman’s thirties rather than decades later.
